Insulin Detemir - CAS 169148-63-4

Insulin Detemir is a long-acting synthetic insulin analogue that effectively controls blood glucose levels by stimulating GLP-1 secretion through enhanced glucagon gene expression and activation of Akt- and/or ERK-dependent signaling pathways. Insulin Detemir is widely employed in type 2 diabetes research to investigate molecular mechanisms of insulin signaling, glucose homeostasis, and therapeutic interventions.

Akt, ERK, Glucagon Receptor

MAPK, Cytoskeletal Signaling, GPCR/G Protein, PI3K/Akt/mTOR signaling

169081

C267H402N64O76S6

-20°C

Ice Packs

Peptide